LUCYNA NIGRO: Open Payments
NPI 1609429166 · HOLYOKE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 10 payments from 9 companies in 2025. Trend: 2023 $1,715 · 2024 $1,392 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $206 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Gilead Sciences, Inc. | 1 | $127 |
| ABBVIE INC. | 1 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $102 |
| Ultragenyx Pharmaceutical Inc. | 1 | $97 |
| Phathom Pharmaceuticals, Inc. | 1 | $89 |
| Viatris Specialty LLC | 1 | $83 |
| GENZYME CORPORATION | 1 | $74 |
Products named: REZDIFFRA, Livdelzi, SKYRIZI, Ozempic, ENTYVIO, Wegovy, VOQUEZNA, YUPELRI.
Industry payments across MA — which companies pay providers there.
